Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial

Keith M Godfrey, Wayne Cutfield, Shiao-Yng Chan, Philip N Baker, Yap-Seng Chong, NiPPeR Study Group, Izzuddin Bin Mohamad Aris, Sheila J Barton, Jonathan Y Bernard, Veronica Boyle, Graham C Burdge, Christopher D Byrne, Shirong Cai, Philip C Calder, Claudia Chi, Caroline E Childs, Mary F Chong, Cathryn Conlon, Cyrus Cooper, Marilou Ebreo, Sarah El-Heis, Marielle Fortier, Lisa R Fries, Nicholas C Harvey, Joanna D Holbrook, Richard Holt, Hazel M Inskip, Neerja Karnani, Timothy Kenealy, Yung Seng Lee, Karen Lillycrop, See Ling Loy, Katherine Macé, Pamela A Mahon, Min Gong, Falk Müller-Riemenschneider, Sharon Ng, Heidi Nield, Justin M O'Sullivan, Wei Wei Pang, Charles Peebles, Anne Rifkin-Graboi, Lesley McCowan, Allan Sheppard, Nick Macklon, Tinu Mary Samuel, Shu E Soh, Lynette Pei-Chi Shek, Irma Silva-Zolezzi, Rachael Taylor, Sagar K Thakkar, Mya Thway Tint, Clare Wall, Wei Ying, Keith M Godfrey, Wayne Cutfield, Shiao-Yng Chan, Philip N Baker, Yap-Seng Chong, NiPPeR Study Group, Izzuddin Bin Mohamad Aris, Sheila J Barton, Jonathan Y Bernard, Veronica Boyle, Graham C Burdge, Christopher D Byrne, Shirong Cai, Philip C Calder, Claudia Chi, Caroline E Childs, Mary F Chong, Cathryn Conlon, Cyrus Cooper, Marilou Ebreo, Sarah El-Heis, Marielle Fortier, Lisa R Fries, Nicholas C Harvey, Joanna D Holbrook, Richard Holt, Hazel M Inskip, Neerja Karnani, Timothy Kenealy, Yung Seng Lee, Karen Lillycrop, See Ling Loy, Katherine Macé, Pamela A Mahon, Min Gong, Falk Müller-Riemenschneider, Sharon Ng, Heidi Nield, Justin M O'Sullivan, Wei Wei Pang, Charles Peebles, Anne Rifkin-Graboi, Lesley McCowan, Allan Sheppard, Nick Macklon, Tinu Mary Samuel, Shu E Soh, Lynette Pei-Chi Shek, Irma Silva-Zolezzi, Rachael Taylor, Sagar K Thakkar, Mya Thway Tint, Clare Wall, Wei Ying

Abstract

Background: Improved maternal nutrition and glycaemic control before and during pregnancy are thought to benefit the health of the mother, with consequent benefits for infant body composition and later obesity risk. Maternal insulin resistance and glycaemia around conception and in early pregnancy may be key determinants of maternal physiology and placental function, affecting fetal nutrient supply and maternal-feto-placental communications throughout gestation, with implications for later postnatal health.

Methods/design: This double-blind randomised controlled trial will recruit up to 1800 women, aged 18-38 years, who are planning a pregnancy in the United Kingdom (UK), Singapore and New Zealand, with a view to studying 600 pregnancies. The primary outcome is maternal glucose tolerance at 28 weeks' gestation following an oral glucose tolerance test. Secondary outcomes include metabolic, molecular and health-related outcomes in the mother and offspring, notably infant body composition. Participants will be randomly allocated to receive a twice-daily control nutritional drink, enriched with standard micronutrients, or a twice-daily intervention nutritional drink enriched with additional micronutrients, myo-inositol and probiotics, both demonstrated previously to assist in maintaining healthy glucose metabolism during pregnancy. Myo-inositol is a nutrient that enhances cellular glucose uptake. The additional micronutrients seek to address deficiencies of some B-group vitamins and vitamin D that are both common during pregnancy and that have been associated with maternal dysglycaemia, epigenetic changes and greater offspring adiposity. Women who conceive within a year of starting the nutritional drinks will be followed through pregnancy and studied with their infants at six time points during the first year of life. Blood, urine/stool, hair and cheek swabs will be collected from the mothers for genetic, epigenetic, hormone, nutrient and metabolite measurements, and assessments of the mother's body composition, anthropometry, health, diet and lifestyle will be made. Infants will also undergo hair, cheek swab, urine and stool sampling for similar biological measurements; infant body composition will be assessed and feeding recorded.

Discussion: There is an increasing focus on the need to optimise maternal nutrition starting prior to conception. This trial will provide evidence on the potential for nutritional interventions beginning prior to conception to promote healthy maternal and offspring outcomes.

Trial registration: ClinicalTrials.gov, identifier: NCT02509988 , Universal Trial Number U1111-1171-8056. Registered on 16 July 2015. This is an academic-led study by the EpiGen Global Research Consortium.

Keywords: Body composition; Glucose metabolism; Hyperglycemia; Metabolic diseases; Nutrition; Preconception; Pregnancy; Randomised trial.

Figures

Fig. 1
Fig. 1
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure: trial schema. Abbreviations: PCV preconception visit, PC preconception, PGV pregnancy visit, PDV post-delivery visit, BIA bioelectrical impedance analysis, BP blood pressure, DM diabetes mellitus, DXA dual-energy X-ray absorptiometry, GDM gestational diabetes, HIV, human immunodeficiency virus, IFG impaired fasting glucose, IGT impaired glucose tolerance, NGT normal glucose tolerance, OGTT oral glucose tolerance test, USS, ultrasound scan. Questionnaires: BEBQ baby eating behaviour, BM breast milk, FH family history, GH general health, IFH infant feeding and health, IIF intentions for infant feeding, L lifestyle, M mood (Edinburgh Postnatal Depression Scale, State-Trait Anxiety Inventory), MH medical history, MSH menstrual history, MTH maternal health, N nutrition/diet, OH obstetric history, PA physical activity, S sleep. Biosampling: # = blood, ♥ = breast milk, $ = buccal swabs, * = epithelial swabs, @ = hair, ^ = stool, ~ = urine

References

    1. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(Suppl 2):S141–6. doi: 10.2337/dc07-s206.
    1. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet. 2009;373:1789–97. doi: 10.1016/S0140-6736(09)60515-8.
    1. Poston L. Developmental programming and diabetes—The human experience and insight from animal models. Best Pract Res Clin Endocrinol Metab. 2010;24:541–52. doi: 10.1016/j.beem.2010.05.007.
    1. Simeoni U, Barker DJ. Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med. 2009;14:119–24. doi: 10.1016/j.siny.2009.01.002.
    1. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49:2208–11. doi: 10.2337/diabetes.49.12.2208.
    1. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–9. doi: 10.2337/db08-1112.
    1. Tam WH, Ma RC, Yang X, Li AM, Ko GT, Kong AP, Lao TT, Chan MH, Lam CW, Chan JC. Glucose intolerance and cardiometabolic risk in adolescents exposed to maternal gestational diabetes: a 15-year follow-up study. Diabetes Care. 2010;33:1382–4. doi: 10.2337/dc09-2343.
    1. Ma RC, Chan JC. Pregnancy and diabetes scenario around the world: China. Int J Gynaecol Obstet. 2009;104(Suppl 1):S42–5. doi: 10.1016/j.ijgo.2008.11.032.
    1. Yajnik CS. Fetal programming of diabetes: still so much to learn! Diabetes Care. 2010;33:1146–8. doi: 10.2337/dc10-0407.
    1. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:408–18. doi: 10.1016/S0140-6736(09)60937-5.
    1. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40. doi: 10.1001/jama.2009.726.
    1. Godfrey KM, Reynolds RM, Prescott SL, Nyirenda M, Jaddoe VWV, Eriksson JG, Broekman BFP. The influence of maternal obesity on the long-term health of the offspring. Lancet Diabetes Endocrinol. 2017;5:53–64. doi: 10.1016/S2213-8587(16)30107-3.
    1. Aris IM, Soh SE, Tint MT, Liang S, Chinnadurai A, Saw SM, Rajadurai VS, Kwek K, Meaney MJ, Godfrey KM, Gluckman PD, Yap FK, Chong YS, Lee YS. Effect of maternal glycemia on neonatal adiposity in a multiethnic Asian birth cohort. J Clin Endocrinol Metab. 2014;99:240–7. doi: 10.1210/jc.2013-2738.
    1. Zhao P, Liu E, Qiao Y, Katzmarzyk PT, Chaput JP, Fogelholm M, Johnson WD, Kuriyan R, Kurpad A, Lambert EV, Maher C, Maia JA, Matsudo V, Olds T, Onywera V, Sarmiento OL, Standage M, Tremblay MS, Tudor-Locke C, Hu G, ISCOLE Research Group Maternal gestational diabetes and childhood obesity at age 9–11: results of a multinational study. Diabetologia. 2016;59:2339–48. doi: 10.1007/s00125-016-4062-9.
    1. Dudley KJ, Sloboda DM, Connor KL, Beltrand J, Vickers MH. Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. PLoS One. 2011;6:e21662. doi: 10.1371/journal.pone.0021662.
    1. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007;50:938–48. doi: 10.1097/GRF.0b013e31815a5494.
    1. Lewis RM, Demmelmair H, Gaillard R, Godfrey KM, Hauguel-de Mouzon S, Huppertz B, Larque E, Saffery R, Symonds ME, Desoye G. The placental exposome: placental determinants of fetal adiposity and postnatal body composition. Ann Nutr Metab. 2013;63:208–15. doi: 10.1159/000355222.
    1. Kuzawa CW. Fetal origins of developmental plasticity: are fetal cues reliable predictors of future nutritional environments? Am J Hum Biol. 2005;17:5–21. doi: 10.1002/ajhb.20091.
    1. Susa JB, Schwartz R. Effects of hyperinsulinemia in the primate fetus. Diabetes. 1985;34(Suppl 2):36–41. doi: 10.2337/diab.34.2.S36.
    1. de Santis MS, Taricco E, Radaelli T, Spada E, Rigano S, Ferrazzi E, Milani S, Cetin I. Growth of fetal lean mass and fetal fat mass in gestational diabetes. Ultrasound Obstet Gynecol. 2010;36:328–37. doi: 10.1002/uog.7575.
    1. Godfrey KM, Haugen G, Kiserud T, Inskip HM, Cooper C, Harvey NCW, Crozier SR, Robinson SM, Davies L, the Southampton Women’s Survey Study Group. Hanson MA. Fetal liver blood flow distribution: role in human developmental strategy to prioritize fat deposition versus brain development. PLoS One. 2012;7:e41759. doi: 10.1371/journal.pone.0041759.
    1. Egeland GM, Skjaerven R, Irgens LM. Birth characteristics of women who develop gestational diabetes: population based study. BMJ. 2000;321:546–7. doi: 10.1136/bmj.321.7260.546.
    1. Lauenborg J, Grarup N, Damm P, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T. Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab. 2009;94:145–50. doi: 10.1210/jc.2008-1336.
    1. Konig M, Shuldiner AR. The genetic interface between gestational diabetes and type 2 diabetes. J Matern Fetal Neonatal Med. 2011;25(1):36–40. doi: 10.3109/14767058.2012.626926.
    1. Graves E, Hill DJ, Evers S, et al. The impact of abnormal glucose tolerance and obesity on fetal growth. J Diabetes Res. 2015;2015:847674. doi: 10.1155/2015/847674.
    1. Gibson KS, Waters TP, Catalano PM. Maternal weight gain in women who develop gestational diabetes mellitus. Obstet Gynecol. 2012;119:560–5. doi: 10.1097/AOG.0b013e31824758e0.
    1. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278:1078–83. doi: 10.1001/jama.1997.03550130052036.
    1. Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence—effect of ethnicity and parity: a meta-analysis. Am J Obstet Gynecol. 2015;213:310–7. doi: 10.1016/j.ajog.2015.03.011.
    1. Godfrey KM, Costello PM, Lillycrop KA. The developmental environment, epigenetic biomarkers and long-term health. J Dev Orig Health Dis. 2015;6:399–406. doi: 10.1017/S204017441500121X.
    1. Dowse GK, Zimmet PZ, Finch CF, Collins VR. Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the ‘thrifty genotype’. Am J Epidemiol. 1991;133:1093–104. doi: 10.1093/oxfordjournals.aje.a115822.
    1. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325:157–60. doi: 10.1136/bmj.325.7356.157.
    1. Crozier SR, Harvey NC, Inskip HM, Godfrey KM, Cooper C, Robinson SM, SWS Study Group Maternal vitamin D status in pregnancy is associated with adiposity in the offspring. Findings from the Southampton Women’s Survey. Am J Clin Nutr. 2012;96:57–63. doi: 10.3945/ajcn.112.037473.
    1. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C, Rodford J, Slater-Jefferies JL, Garratt E, Crozier SR, Emerald BS, Gale CR, Inskip HM, Cooper C, Hanson MA. Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes. 2011;60:1528–34. doi: 10.2337/db10-0979.
    1. Childs C, Titcombe P, Crozier S, Barton S, Harvey N, Cooper C, Inskip H, Godfrey K. Low B-vitamin status during pregnancy is associated with greater offspring adiposity in childhood. J Dev Orig Health Dis. 2015;6(Suppl 2):S36.
    1. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, Bhat DS, Naik SS, Coyaji KJ, Joglekar CV, Joshi N, Lubree HG, Deshpande VU, Rege SS, Fall CH. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia. 2008;51:29–38. doi: 10.1007/s00125-007-0793-y.
    1. Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CL, Yajnik CS, Fall CH. Low plasma vitamin B12 in pregnancy is associated with gestational ‘diabesity’ and later diabetes. Diabetologia. 2009;52:2350–8. doi: 10.1007/s00125-009-1499-0.
    1. Lu M, Xu Y, Lv L, Zhang M. Association between vitamin D status and the risk of gestational diabetes mellitus: a meta-analysis. Arch Gynecol Obstet. 2016;293:959–66. doi: 10.1007/s00404-016-4010-4.
    1. Asemi Z, Hashemi T, Karamali M, Samimi M, Esmaillzadeh A. Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr. 2013;98:1425–32. doi: 10.3945/ajcn.113.072785.
    1. Bo S, Lezo A, Menato G, Gallo ML, Bardelli C, Signorile A, Berutti C, Massobrio M, Pagano GF. Gestational hyperglycemia, zinc, selenium, and antioxidant vitamins. Nutrition. 2005;21:186–91. doi: 10.1016/j.nut.2004.05.022.
    1. Schlemmer U, Frolich W, Prieto RM, et al. Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res. 2009;53(Suppl 2):S330–75. doi: 10.1002/mnfr.200900099.
    1. Clements RS, Diethelm AG. The metabolism of myo-inositol by the human kidney. J Lab Clin Med. 1979;93:210–9.
    1. Hauser G, Finelli VN. The biosynthesis of free and phosphatide myo-inositol from glucose by mammalian tissue slices. J Biol Chem. 1963;238:3224–8.
    1. Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013;95:1811–27. doi: 10.1016/j.biochi.2013.05.011.
    1. Coustan DR. Can a dietary supplement prevent gestational diabetes mellitus? Diabetes Care. 2013;36:777–9. doi: 10.2337/dc12-2505.
    1. Foster SR, Omoruyi FO, Bustamante J, Lindo RL, Dilworth LL. The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats. Int J Exp Pathol. 2016;97:397-407.
    1. D’Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, Corrado F, Di Benedetto A. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013;36:854–7. doi: 10.2337/dc12-1371.
    1. Corrado F, D’Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, Di Benedetto A. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011;28:972–5. doi: 10.1111/j.1464-5491.2011.03284.x.
    1. D’Anna R, Di Benedetto V, Rizzo P, Raffone E, Interdonato ML, Corrado F, Di Benedetto A. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol. 2012;28:440–2. doi: 10.3109/09513590.2011.633665.
    1. Matarrelli B, Vitacolonna E, D’angelo M, Pavone G, Mattei PA, Liberati M, Celentano C. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013;26:967–72. doi: 10.3109/14767058.2013.766691.
    1. Cani PD, Geurts L, Matamoros S, Plovier H, Duparc T. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab. 2014;40:246–57. doi: 10.1016/j.diabet.2014.02.004.
    1. Isolauri E, Rautava S, Collado MC, Salminen S. Role of probiotics in reducing the risk of gestational diabetes. Diabetes Obes Metab. 2015;17:713–9. doi: 10.1111/dom.12475.
    1. Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr. 2010;103:1792–9. doi: 10.1017/S0007114509993898.
    1. Catalano P, deMouzon SH. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. Int J Obes. 2015;39:642–9. doi: 10.1038/ijo.2015.15.
    1. Norwegian Scientific Committee for Food Safety. .
    1. Kumar R, Ouyang F, Story RE, Pongracic JA, Hong X, Wang G, Pearson C, Ortiz K, Bauchner H, Wang X. Gestational diabetes, atopic dermatitis, and allergen sensitization in early childhood. J Allergy Clin Immunol. 2009;124:1031–8. doi: 10.1016/j.jaci.2009.06.052.
    1. Lawlor DA, Wills AK, Fraser A, Sayers A, Fraser WD, Tobias JH. Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study. Lancet. 2013;381:2176–83. doi: 10.1016/S0140-6736(12)62203-X.

Source: PubMed

3
Abonnieren